Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.

Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S. Food and Drug Administration.

The End the Vaccine Carveout Act would expose vaccine makers to lawsuits that once drove companies out of the industry.

But just a week lat­er, on Feb. 18, the FDA back­tracked on its decision, saying that it will indeed review the vaccine, potentially in time for its approval for the ...

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But ...

The FDA approved a vaccine for mumps nearly 60 years ago, so why are some areas of the United States experiencing outbreaks now, and who should be concerned?

Vietnam has launched clinical trials of a new antiviral drug that could offer fresh hope in the fight against dengue fever, a disease that still has no approved specific treatment worldwide.

Former assistant professor of epidemiology, immunology, and infectious disease at the Harvard T.H. Chan School of Public Health and pathology at ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...

The political and scientific fight over the COVID vaccines rages on, years later, with the belated acknowledgment by the FDA there were likely a small number of children killed by ...

A Justice Department lawyer argued that the HHS secretary has broad discretion to issue vaccine guidance and choose what ...

A lawyer for the Trump administration told a judge on Wednesday that Health and Human Services Secretary Robert F. Kennedy Jr. has such broad authority over vaccine policy that he could even ​scrap ...